This press release was originally posted by the Dengue Vaccine Initiative.

WASHINGTON, DC – July 24, 2015 – The Dengue Vaccine Initiative (DVI) a consortium comprised of the International Vaccine Institute, the Johns Hopkins University’s International Vaccine Access Center, Sabin Vaccine Institute and the World Health Organization, is delighted to announce the appointment of Dr. In-Kyu Yoon as its new Director. Dr. Yoon, former Chief of the Department of Virology, Armed Forces Research Institute Medical Sciences in Bangkok, Thailand, will lead DVI starting August, 2015.
"We greatly look forward to Dr. Yoon’s leadership of DVI," said Dr. Jerome Kim, the International Vaccine Institute’s Director General. "Dr. Yoon’s extensive research experience and knowledge of dengue and vaccine clinical trials will further strengthen DVI’s management and operations. His experience will be welcomed by the International Vaccine Institute as he can also provide additional scientific leadership at the Institute."
In his previous position, Dr. Yoon investigated arbovirus and respiratory virus infections including clinical trials of candidate vaccines. He has conducted research on the epidemiology, pathophysiology and immunology of dengue and other emerging infectious diseases, was a faculty member of the Uniformed Services University of the Health Sciences in Maryland, United States and authored over 70 publications and provided clinical care in a variety of civilian and military settings internationally.
"DVI and its predecessor, PDVI, have provided leadership and continuity in dengue vaccine research over many years," said Joachim Hombach, DVI member and Coordinator of the Initiative for Vaccine Research at the World Health Organization. "We are very happy to welcome the new leadership in these very important and exciting times, as a first dengue vaccine is being reviewed for registration. Dr. Yoon is an accomplished dengue researcher and clinical practitioner and we look forward to working with him."
Dr. Yoon graduated magna cum laude with a bachelor’s degree in paleobiology from Yale University in 1988 and received his MD from the New York University School of Medicine in 1993. He completed residency training in Internal Medicine and fellowship training in Allergy/Immunology at the Walter Reed Army Medical Center.
"I’m excited to lead the Dengue Vaccine Initiative during this critical period in the development and implementation of dengue vaccines. DVI and PDVI have played a crucial role over the past 12 years in advancing the field of dengue vaccines. As we move forward, DVI will continue to work diligently to promote measures to prevent and control this global problem," commented Dr. Yoon on his new endeavor.
Join us in welcoming Dr. Yoon to DVI and the dengue prevention community.
About DVI
DVI is an international consortium that specializes in epidemiology and other research, health economics, policy and advocacy to equip countries with objective information and scientific evidence to fight dengue fever, a widespread mosquito-borne disease which causes an estimated 390 million infections a year in over 120 countries. The Initiative is supported in part by the Bill & Melinda Gates Foundation.


Media Contact
Rebecca Van Roy